$41.220
-0.111 (-0.27%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BN Prediction & Forecast by Similar Chart Analysis
Alphio's BN stock price prediction model matches the current Brookfield Corporation tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $40.66 (+2.32%). The 1-week path is $40.62 (+2.21%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Brookfield Corporation Stock?
Brookfield Corp is currently priced at $41.33, which is below the average analyst price target of $59, indicating potential upside. However, the RSI is at 28.236, suggesting the stock is oversold, but it also reflects a bearish trend. The forward P/E ratio is 11.89, which is attractive compared to its current P/E of 64.58, indicating that the stock may be undervalued. The main risk is the recent performance, with a year-to-date change of -11.37%, indicating a downward trend that could continue in the short term.
BN stock price ended at $41.22 on Monday, after losing -0.27%
Brookfield Corporation (BN) last closed at $39.74, losing -3.59%. These facts feed the 1-day and 1-week BN price prediction above.
Forecast Drivers
Brookfield Corporation (BN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BN, ranked by similarity.
Seasonality analysis for BN
Historically the probability of a positive September return for BN is 97.62%. October offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.